163 related articles for article (PubMed ID: 12005274)
1. Frovatriptan for the acute treatment of migraine: a dose-finding study.
Goldstein J; Keywood C;
Headache; 2002 Jan; 42(1):41-8. PubMed ID: 12005274
[TBL] [Abstract][Full Text] [Related]
2. Dose range-finding studies with frovatriptan in the acute treatment of migraine.
Rapoport A; Ryan R; Goldstein J; Keywood C
Headache; 2002 Apr; 42 Suppl 2():S74-83. PubMed ID: 12028323
[TBL] [Abstract][Full Text] [Related]
3. Tolerability and safety of frovatriptan with short- and long-term use for treatment of migraine and in comparison with sumatriptan.
Géraud G; Spierings EL; Keywood C
Headache; 2002 Apr; 42 Suppl 2():S93-9. PubMed ID: 12028325
[TBL] [Abstract][Full Text] [Related]
4. Frovatriptan: a review of its use in the acute treatment of migraine.
Sanford M
CNS Drugs; 2012 Sep; 26(9):791-811. PubMed ID: 22900951
[TBL] [Abstract][Full Text] [Related]
5. Frovatriptan as preemptive treatment for fasting-induced migraine.
Latsko M; Silberstein S; Rosen N
Headache; 2011 Mar; 51(3):369-374. PubMed ID: 21269298
[TBL] [Abstract][Full Text] [Related]
6. Safety and tolerability of short-term preventive frovatriptan: a combined analysis.
MacGregor EA; Brandes JL; Silberstein S; Jeka S; Czapinski P; Shaw B; Pawsey S
Headache; 2009 Oct; 49(9):1298-314. PubMed ID: 19788471
[TBL] [Abstract][Full Text] [Related]
7. A randomized trial of frovatriptan for the intermittent prevention of menstrual migraine.
Silberstein SD; Elkind AH; Schreiber C; Keywood C
Neurology; 2004 Jul; 63(2):261-9. PubMed ID: 15277618
[TBL] [Abstract][Full Text] [Related]
8. Safety and tolerability of frovatriptan in the acute treatment of migraine and prevention of menstrual migraine: Results of a new analysis of data from five previously published studies.
MacGregor EA; Pawsey SP; Campbell JC; Hu X
Gend Med; 2010 Apr; 7(2):88-108. PubMed ID: 20435272
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and pharmacokinetic activity of frovatriptan compared to rizatriptan in patients with moderate-to-severe migraine.
Savi L; Mogavero S; Egan CG
Drug Des Devel Ther; 2014; 8():983-92. PubMed ID: 25092964
[TBL] [Abstract][Full Text] [Related]
10. Frovatriptan succinate, a 5-HT1B/1D receptor agonist for migraine.
Balbisi EA
Int J Clin Pract; 2004 Jul; 58(7):695-705. PubMed ID: 15311727
[TBL] [Abstract][Full Text] [Related]
11. Comparison of frovatriptan plus dexketoprofen (25 mg or 37.5 mg) with frovatriptan alone in the treatment of migraine attacks with or without aura: a randomized study.
Tullo V; Valguarnera F; Barbanti P; Cortelli P; Sette G; Allais G; d'Onofrio F; Curone M; Zava D; Pezzola D; Benedetto C; Frediani F; Bussone G
Cephalalgia; 2014 May; 34(6):434-45. PubMed ID: 24363238
[TBL] [Abstract][Full Text] [Related]
12. Frovatriptan review.
Markus F; Mikko K
Expert Opin Pharmacother; 2007 Dec; 8(17):3029-33. PubMed ID: 18001261
[TBL] [Abstract][Full Text] [Related]
13. Frovatriptan.
Easthope SE; Goa KL
CNS Drugs; 2001; 15(12):969-76; discussion 977-8. PubMed ID: 11735616
[TBL] [Abstract][Full Text] [Related]
14. Randomized, placebo-controlled comparison of early use of frovatriptan in a migraine attack versus dosing after the headache has become moderate or severe.
Cady R; Elkind A; Goldstein J; Keywood C
Curr Med Res Opin; 2004 Sep; 20(9):1465-72. PubMed ID: 15383196
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of two 6-day frovatriptan dosing regimens used for the short-term prevention of menstrual migraine: A phase I, randomized, double-blind, placebo-controlled, two-period crossover, single-centre study in healthy female volunteers.
Wade A; Pawsey S; Whale H; Boyce M; Warrington S
Clin Drug Investig; 2009; 29(5):325-37. PubMed ID: 19366274
[TBL] [Abstract][Full Text] [Related]
16. Scheduled short-term prevention with frovatriptan for migraine occurring exclusively in association with menstruation.
Silberstein SD; Berner T; Tobin J; Xiang Q; Campbell JC
Headache; 2009 Oct; 49(9):1283-97. PubMed ID: 19751371
[TBL] [Abstract][Full Text] [Related]
17. Clinical efficacy of frovatriptan: placebo-controlled studies.
Ryan R; Géraud G; Goldstein J; Cady R; Keywood C
Headache; 2002 Apr; 42 Suppl 2():S84-92. PubMed ID: 12028324
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and tolerability of frovatriptan in acute migraine treatment: systematic review of randomized controlled trials.
Poolsup N; Leelasangaluk V; Jittangtrong J; Rithlamlert C; Ratanapantamanee N; Khanthong M
J Clin Pharm Ther; 2005 Dec; 30(6):521-32. PubMed ID: 16336284
[TBL] [Abstract][Full Text] [Related]
19. Rapid responders to frovatriptan in acute migraine treatment: results from a long-term, open-label study.
Spierings EL; Keywood C
Pain Med; 2009; 10(4):633-8. PubMed ID: 19453958
[TBL] [Abstract][Full Text] [Related]
20. Early (≤ 1-h) vs. late (>1-h) administration of frovatriptan plus dexketoprofen combination vs. frovatriptan monotherapy in the acute treatment of migraine attacks with or without aura: a post hoc analysis of a double-blind, randomized, parallel group study.
Allais G; Bussone G; Tullo V; Cortelli P; Valguarnera F; Barbanti P; Sette G; Frediani F; D'Arrigo G; d'Onofrio F; Comi G; Curone M; Colombo B; Omboni S; Benedetto C
Neurol Sci; 2015 May; 36 Suppl 1():161-7. PubMed ID: 26017535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
